BCL2 and acute myeloid leukemia: Many drugs are used to treat AML, including FLT3 inhibitors (midostaurin), IDH inhibitors (ivosidenib and enasidenib), hedgehog pathway inhibitors (glasdegib), Bcl-2 inhibitors (venetoclax), and proteasome inhibitors (bortezomib).